2023-08-15 13:45:59
Researcher Explores Strategies to Combat Global Antibiotic Resistance Increase
In his inaugural lecture, Professor Mark de Boer, an expert in infectious diseases and antimicrobial resistance, highlighted the urgent need for modern medicine to anticipate the global rise in antibiotic resistance. De Boer emphasized the importance of finding the right balance between over- and under-treatment with antibiotics, which he believes can be achieved through a system-wide approach and the collaboration of physicians and scientists.
De Boer first addressed the concept of “One Health,” as advocated by the World Health Organisation, which emphasizes the interconnectedness of sectors such as agriculture, industry, and healthcare in combating antibiotic resistance. While some European countries have implemented research programs and subsidies to promote this approach, De Boer acknowledged that many countries still lack a concrete plan. Factors such as politics, war, and poverty further hinder progress in countries where tackling antibiotic resistance is most critical.
Highlighting the international nature of antibiotic resistance, De Boer pointed out that bacteria and resistance mechanisms do not respect national borders. Travel and globalization play significant roles in the spread of antibiotic resistance, as seen in the case of the NDM-1 superbug originating from India. To effectively address this issue, De Boer stressed the need for sustainable development goals that consider the interconnectedness of different sectors.
Furthermore, De Boer emphasized the crucial role of physicians and scientists in determining appropriate treatment strategies. As antibiotic resistance grows, it has become clear that infectious disease treatment requires a multidisciplinary approach involving internists, microbiologists, and infectiologists. Regular multidisciplinary meetings in hospitals, where infectious complications are discussed, have proven beneficial in improving cooperation among different specialties.
De Boer also outlined two key research areas in his quest to combat antibiotic resistance. The first area focuses on antibiotic tolerance and its contribution to resistance development. Understanding this phenomenon may lead to more patient-specific treatment plans. The second area centers on biofilm-associated infections and exploring alternative treatment options that are less invasive and rely on targeted drug therapy.
In conclusion, De Boer urged the medical community to exploit the opportunities available to improve antibiotic policies. While acknowledging the importance of antibiotics in modern medicine, he emphasized the need to review and improve their application to slow down the development of antimicrobial resistance. However, De Boer expressed frustrations with current GDPR legislation, which hinders researchers’ access to patient data necessary for effective research.
As antibiotic resistance continues to pose a significant threat, Professor Mark de Boer’s groundbreaking research and comprehensive approach offer hope in the fight against this global health crisis.]
#search #responsible #antibiotic